In the intensive care units where cancer and sepsis converge, physicians have long wrestled with a deceptively simple question: how much blood is enough? A decade-long retrospective study of 658 critically ill patients now offers a measured answer — that neither a cautious nor a generous transfusion threshold appears to determine survival, though the body's kidneys may register the difference in ways mortality statistics cannot fully capture. The findings do not resolve the debate so much as clarify its contours, reminding us that in medicine, as in life, the absence of a clear answer is itsel
Transfusion Strategy Shows No Mortality Difference in Cancer Patients With Sepsis
658 critically ill cancer patients with sepsis were studied; outcomes included mortality and organ dysfunction rates, with no specific casualty figures provided.